No Data
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Shareholders in AtriCure (NASDAQ:ATRC) Have Lost 58%, as Stock Drops 3.3% This Past Week
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
AtriCure Coverage Assumed by JP Morgan at Overweight
J.P. Morgan Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $40